Drugs of abuse -- Analysis -- Statistical methods : Guidelines on representative drug sampling / Laboratory and Scientific Section, United Nations Office on Drugs and Crime, Vienna in cooperation with the Drugs Working Group of the European Network of Forensic Science Institutes
Drugs of abuse -- Environmental aspects : Illicit Drugs in the Environment : Occurrence, Analysis, and Fate Using Mass Spectrometry / edited by Sara Castiglioni, Ettore Zuccato, Roberto Fanelli
Drugs of abuse -- Health aspects -- Australia. : Illicit drugs policy : using evidence to get better outcomes / Royal Australasian College of Physicians (RACP) and the Royal Australian and New Zealand College of Psychiatrists
2004
1
Drugs of abuse -- Health aspects -- New Zealand. : Illicit drugs policy : using evidence to get better outcomes / Royal Australasian College of Physicians (RACP) and the Royal Australian and New Zealand College of Psychiatrists
Drugs of abuse -- Identification : Guidelines for the import and export of drug and precursor reference standards : for use by national drug testing laboratories and competent national authorities = Principes directeurs pour l'importation e l'exportation d'étalons de référence de drogues et de précurseurs : à l'usage des laboratoires nationaux d'analyse des drogues et des autorités nationales compétentes / United Nations Office on Drugs and Crime, Vienna
Drugs of abuse -- Spectra : Illicit Drugs in the Environment : Occurrence, Analysis, and Fate Using Mass Spectrometry / edited by Sara Castiglioni, Ettore Zuccato, Roberto Fanelli
2011
1
Drugs of abuse -- Standards : Guidelines for the import and export of drug and precursor reference standards : for use by national drug testing laboratories and competent national authorities = Principes directeurs pour l'importation e l'exportation d'étalons de référence de drogues et de précurseurs : à l'usage des laboratoires nationaux d'analyse des drogues et des autorités nationales compétentes / United Nations Office on Drugs and Crime, Vienna
Drugs of limited commercial value -- See Orphan drugs
Here are entered works on drugs which appear to be useful for the treatment of rare disorders, but have difficulty in finding a sponsor for development and marketing because of insufficient anticipated financial return